Related Experiment Videos
[Multivariate analysis for prognostic predictors in non-small cell lung cancer].
1Department of Radiation Oncology , Cancer Hospital, Medical Center , Fundan University ( Former Shanghai Medical University ) , Shanghai 200032, P. R. China.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|November 26, 2010
Summary
Late stage, lymphatic invasion, and multiple oncoprotein overexpression predict poor outcomes in non-small cell lung cancer (NSCLC). A prognostic index (PI) effectively identifies high-risk NSCLC patients.
Area of Science:
- Oncology
- Cancer Biology
- Biostatistics
Context:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality.
- Accurate prognostic predictors are crucial for tailoring treatment strategies in NSCLC.
- Previous studies have identified various clinical and pathological factors, but comprehensive multivariate analysis is needed.
Purpose:
- To identify independent prognostic predictors for non-small cell lung cancer (NSCLC) using multivariate analysis.
- To develop a prognostic index (PI) for stratifying NSCLC patients into different risk groups.
- To evaluate the correlation between oncoprotein overexpression and patient outcomes.
Summary:
- A study of 158 NSCLC patients treated between 1981-1994 analyzed clinical, histological, and molecular factors.
- Multivariate analysis revealed that advanced TNM stage (T and N), lymphatic vessel invasion, and multi-oncoprotein overexpression were significant unfavorable prognostic predictors.
- A prognostic index (PI) was developed, enabling stratification into good (77% 5-year survival), moderate (45%), and bad (21%) prognosis groups.
Impact:
- The findings provide valuable prognostic markers for NSCLC patients.
- The developed prognostic index (PI) can aid clinicians in risk stratification and personalized treatment planning.
- This research contributes to a better understanding of the molecular mechanisms underlying NSCLC progression and metastasis.
